TriangleFOR PATIENTS · SOURCE READING
Aggressive Non-Hodgkin Lymphoma During Pregnancy
Source: Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: August 22, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Named disease and setting sections within a broader NCI patient summary Only the named source sections and descendants are joined. Parent source is broader; original patient terminology and grade/setting constraints must remain visible.
Context: Treatment of Non-Hodgkin Lymphoma During Pregnancy
Treatment of aggressive non-Hodgkin lymphoma during pregnancy may include the following:
Source links and citations
Treatment given right away based on the type of non-Hodgkin lymphoma to increase the mother's chance of survival. Treatment may include combination chemotherapy and rituximab.
Source links and citations
Early delivery of the baby followed by treatment based on the type of non-Hodgkin lymphoma.
If in the first trimester of pregnancy, medical oncologists may advise ending the pregnancy so that treatment may begin. Treatment depends on the type of non-Hodgkin lymphoma.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice